French artificial intelligence startup Bioptomus, pioneers of the biology research model family H-Optomus, today announced the availability of the company’s next-gen clinical biology AI model, ...
We know the numbers by heart: bringing a new drug to market requires, on average, 12–15 years and about $1 billion. And despite the record investment in R&D in 2007 ($58.8 billion), the development of ...
In an interview with VentureBeat, Jean-Philippe Vert, co-founder and CEO of Bioptimus, chief R&D Officer of Owkin and former research lead at Google Brain, said as a smaller, independent company, ...
LABLINES: “Linking Arts and Biology through Lines & Narrative for Engaging Science,“ is set to launch at Tufts this semester. The initiative recently received a grant from the Tufts MUSE funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results